American Society of Gene Therapy Annual Meeting (2009-2013)

美国基因治疗学会年会（2009-2013）

• 批准号: 7749863
• 负责人: KENNETH CORNETTA
• 金额: $ 1万
• 依托单位: AMERICAN SOCIETY OF GENE & CELL THERAPY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7749863
• 关键词: American; Arts; Award; Cell Therapy; Cells; Development; Educational Grants; Ethical Issues; Ethicists; Fostering; Funding; Genes; Grant; Human; National Heart, Lung, and Blood Institute; Oral; Participant; Peer Review; Postdoctoral Fellow; Request for Proposals; Research; Research Personnel; Scientific Advances and Accomplishments; Scientist; Senior Scientist; Societies; Students; Technology; Thinking; Training; Travel; United States National Institutes of Health; Work; abstracting; base; gene therapy; innovation; insight; meetings; member; novel; posters; programs; public education; symposium

DESCRIPTION (provided by applicant): The American Society of Gene Therapy was founded in 1996 and is dedicated to the development of gene and cell therapies with a particular focus on professional and public education. Our Annual Meeting represents the major educational initiative of the Society and has been CME accredited for all of our prior 11 meetings. This R13 proposal requests support for travel grants and an educational program for trainees. Over 1/4 of our members are scientists in training working to develop clinically applicable gene-based technologies. Trainee participation in the Annual Meeting is fostered by an outstanding educational program, trainee travel awards, and recognition of outstanding scientific accomplishments through peer-reviewed trainee Excellence in Research Awards. Over the past decade, the ASGT has offered 470 travel grants and 63 Research Awards, with 20 travel grants per year for the past 5 years made possible by an R13 grant from the NHLBI. Educational opportunities for travel awardees include outstanding plenary speakers, state-of-the-art scientific symposia, and educational sessions that review current thinking on a variety of topics. In addition to leading scientists and clinicians, the program includes ethicists and representatives from the FDA, OBA, and NIH so young scientists may gain insight into the compliance and ethical issues related to human gene therapy. Trainees are active presenters in oral abstract and poster presentations and the top trainee abstracts are recognized at the Presidential Symposium. This proposal also requests partial support of a novel "Meet the Expert" program that allows trainees to interact with gene therapy leaders in a small group setting. The size of the ASGT meeting (approximately 2,000 participants) is ideally suited to expose young scientists to leaders in the field, yet provide opportunities for trainees to present their work at the premier meeting in the field of gene and cell therapy. Continued NIH support for the ASGT Annual Meeting will allow continued educational and professional advancement of trainees in the field of cell and gene therapy. (End of Abstract)

描述（由申请人提供）： 美国基因疗法学会成立于1996年，致力于开发基因和细胞疗法，特别关注专业和公共教育。我们的年度会议代表了该协会的主要教育计划，并且在我们之前的所有11次会议上都获得了CME认可。该R13提案要求提供旅行赠款和针对受训者的教育计划。我们超过1/4的成员是培训培训以开发临床适用基因技术的科学家。受训者参加年度会​​议的参加者由杰出的教育计划，学员旅行奖，以及通过同行评审的研究奖卓越的卓越学员的杰出科学成就的认可。在过去的十年中，ASGT提供了470次旅行补助金和63个研究奖，在过去的5年中，NHLBI的R13赠款每年提供20次旅行补助金。获奖者的教育机会包括出色的全体演讲者，最先进的科学专题讨论会和教育会议，以回顾有关各种主题的当前思想。除了领先的科学家和临床医生外，该计划还包括来自FDA，OBA和NIH的伦理学家和代表，因此年轻的科学家可能会深入了解与人类基因治疗相关的合规性和道德问题。学员是口头摘要和海报演讲中的活跃演示者，在总统专题讨论会上认可了最高学员的摘要。该提案还要求部分支持小说的“遇见专家”计划，该计划允许受训者在小组环境中与基因治疗领袖互动。 ASGT会议的规模（大约2,000名参与者）非常适合将年轻科学家暴露于该领域的领导者，但为受训者提供了在基因和细胞疗法领域的总理会议上介绍其工作的机会。 NIH对ASGT年度会议的持续支持将允许在细胞和基因疗法领域的学员继续教育和专业发展。 （抽象的结尾）